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INTRODUCTION
The vestibular schwannoma (VS) is essentially a benign
disease and its malignant transformation is to be exception-
al. In this regard, malignant recurrence after surgery of VS
is a very rare event and there has been only one report on
malignant transformation of VS (1). Here we report a case




A 33-yr-old woman presented with intermittent severe
headache. She had a one-year history of vertigo and docu-
mented recent aggravations of gait disturbance and hearing
difficulty. On admission, neurological examination was sig-
nificant for nystagmus, diplopia, ataxic gait, and sensorineu-
ral hearing loss (pure tone average 65 dB, speech discrimi-
nation score 40%) in her left ear. There were neither stig-
mata of neurofibromatosis nor history of exposure to irradia-
tion. Initial magnetic resonance image (MRI) demonstrated
a well-enhancing large mass, measuring 3×4 cm, in the
left cerebellopontine angle with an enlarged porus acousti-
cus interna (Fig. 1A). Left external carotid artery angiogra-
phy showed a moderately intense tumor blush which was
supplied by meningeal vessels. The clinical diagnosis of VS
was made.
Surgical Procedures and Postoperative Course
A left suboccipital retrosigmoid-transmeatal approach
revealed a large well-marginated, relatively hypervascular
mass at cerebellopontine angle extending into the internal
auditory meatus and surrounding the eighth cranial nerve.
The facial nerve was attenuated and adherent to the tumor
capsule anteriorly. The lower cranial nerves and brain stem
were distorted. The tumor was macroscopically totally resect-
ed with the porus acousticus being explored in the intracanic-
ular portion. No visible residual enhancing tumor was pre-
sent on postoperative computerized tomography. The patient
quickly recovered after the surgery and was discharged with
mild facial weakness and left-ear deafness. However, two
months after the surgery, progressive facial numbness and
weakness, headache, dizziness, and right-sided hemiparesis
were noted. A huge recurrent tumor at original site was dis-
covered in a follow-up MRI (Fig. 1B) which was again com-
pletely removed through the same route of the first opera-
tion. The mass was well-circumscribed with varying consis-
tency without invasion to adjacent structures. At this point,
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Vestibular Schwannoma with Malignant Transformation
: A Case Report
We describe a rare case of malignant transformation in a vestibular schwanno-
ma in a 33-yr-old woman. She presented herself with headache, tinnitus, and
hearing loss and underwent posterior fossa explorations three times during the
short period of 3 months. The clinicopathological features of the original tumor
were typical of benign vestibular schwannoma. Despite a comlpete microsurgi-
cal excision, two months later, the tumor recurred locally with a rapid increase in
size causing a progressive worsening of neurological symptoms. A diagnosis of
malignant schwannoma was made for the recurrent tumor on the basis of the
microscopic findings of high cellularity, moderate pleomorphism, and the pres-
ence of mitotic cells. Repeat magnetic resonance imaging performed a month
after the second surgery unexpectedly showed definite tumor enlargement. She
remained clinically stable following the third debulking of the tumor and adjuvant
radiotherapy. We propose that this recurrent tumor represent malignant transfor-
mation from a benign vestibular schwannoma which was an unusual occurrence
in a patient without neurofibromatosis.
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we considered a possible malignant transformation of schwan-
noma and recommended cranial irradiation as an adjuvant
therapy, but she refused further treatment. A month after
the reexploration, a MRI examination revealed further pro-
gression of the disease (Fig. 1C) that caused clinical deterio-
ration. Without further workup for metastasis, a third micro-
surgery and adjuvant fractionated radiotherapy were per-
formed. Postoperative subcutaneous cerebrospinal fluid
leakage and suboccipital soft-tissue bulging were successful-
ly treated with lumbar drainage. Thereafter, the patient has
been clinically stable for one year until this writing without
any evidence for recurrence on serial MRI.
Pathological Findings
The surgical specimens obtained at the first resection con-
sisted of multiple pieces of pale to yellow-tan, homogeneous,
soft tissue and measured 2.5×2.2×0.9 cm in aggregates.
Microscopic finding demonstrated a tumor predominantly
composed of spindle cells that are arranged in interlacing
fascicles admixed with more loose textured cells (Fig. 2A).
Multiple sections failed to show any evidences of malignant
features and immunostaining for S-100 protein was strong-
ly and uniformly positive in the spindle cells (Fig. 2B). On
the basis of these findings, the histopathological diagnosis
of a benign VS was made. At the first recurrence, the fea-
C
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Fig. 1. Enhanced axial MR images. (A) Preoperative MRI showing
a tumor arising from the porus acousticus that compress the
brain stem and cerebellum. (B) MRI performed at the second
presentation unexpectedly demonstrated aggressive tumor
regrowth with deformation of the fourth ventricle. (C) Image
obtained a month after the reoperation indicates definite tumor
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tures of the tumor was quite different from those of the orig-
inal mass and were compatible with low-grade malignant
schwannoma. Gross examination of the second specimen
revealed several irregular hard fragments of pale-tan tumor
mass measuring 5.5×3.0×3.0 cm in aggregates. The recur-
rent tumor was characterized by extreme hypercellularity,
moderately pleomorphic spindle cells with hyperchromatic
nuclei, and frequent mitoses (Fig. 3A). There were 2-3 mitotic
figures per 10 high-power fields at the active hypercellular
area of recurrent tumor. No focus of hemorrhage or necrosis
was present. Immunohistochemical findings of the recurrent
tumor demonstrated scattered MIB-1-positive cells with 3%
A B
Fig. 2. Neuropathology (H&E) (A) and immunohistochemistry (B) of the initial neoplasm display diffuse proliferation of spindle-shaped
Schwann cells which are strongly immunoreactive for S-100 protein. Some hyalinized blood vessels within the hypocellular myxoid areas
are also noted (×200).
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Fig. 3. Photomicrographs of the first recurrent tumor. (A) This view shows a fascicular arrangement of atypical spindle cells with hyper-
chromatic nuclei and frequent mitoses and increased cellularity compared with the original tumor (H&E, ×200). (B) Immunostaining
reveals focal positivity of the tumor cells with anti-S-100 protein antibody (H&E,×200).820 E.-I. Son, I.-M. Kim, S.-P. Kim
proliferation index and intranuclear deposits of p53 protein
suggesting the tumor recurrence. The second recurrent tumor
showed the similar features both in the histologic composi-
tion and immunohistochemical result: the first recurrent
tumor had weakly and focally positive immunoreactivity for
S-100 protein (Fig. 3B). The third specimen looked white,
firm fibrous tumor and measured 4.5×3.0×1.0 cm in aggre-
gates. We did not measure specimen weight.
DISCUSSION
Malignant cranial nerve schwannomas are rare and occur
most commonly in the trigeminal nerve (2, 3). In recent
reviews, approximately five cases of malignant tumors aris-
ing in the eighth cranial nerve has been reported (1, 4-6), of
which four were malignant triton tumors which consisted
of distinct schwannian and rhabdomyoblastic cell compo-
nents and were first described by Kudo et al. (7). The remain-
ing one case (1) was malignant vestibular nerve tumor of
pure schwannian origin. Those tumors were usually larger
than classic benign VS on presentation. In spite of adjuvant
combination therapy, all malignant VS including the malig-
nant triton tumors exhibit aggressive biological behavior
marked by multiple local recurrence, frequent neuroaxis
dissemination and need for reoperation. They usually pre-
sent in a fashion typical of more common benign VS, but
have distinguishable clinical features by multiple cranial
nerve palsy due to the tumor progression. Regardless of com-
plete surgical removal, the reported cases of malignant VS
showed marked regrowth after a mean interval of 5 months.
The patient described here also showed trigeminal and facial
nerve dysfunctions at the second admission with malignant
recurrence. For the management of patients with malignant
VS, total resection is preferred to reduce the possibility of
recurrence and prompt radiotherapy or radiosurgery is need-
ed for the control of any residual tumor (5, 8). Unfortunate-
ly, however, no long-term survival has been previously re-
ported. For the five reported cases of malignant vestibular
schwannoma, treatment in every case consisted of a surgical
excision preceded or followed in only one instance by radia-
tion therapy. Four of those patients with recurrent tumor
underwent reoperations and resulted in fatal clinical course
postoperatively. Two cases demonstrated drop metastasis at
tumor recurrence. The mean survival in the those five patients
dying with disease was 11 months. We successfully performed
operations three times and anticipate that she will survive
longer than previously reported cases. On the basis of the
previous studies, we would only resort to the option of stereo-
tactic radiosurgery for any tumor progression on the follow-
up MRI.
Malignant schwannomas are rarely derived from a preex-
isting benign solitary schwannoma except for the cases in
association with neurofibromatosis type 1 (9). Postradiation
sarcomatous change is well known but, schwannomas rarely
undergo spontaneous malignant transformation. Woodruff
et al. (10) described only nine cases of spontaneous malig-
nant transformation in all parts of the body. In this series,
two cases showed malignant transformed schwannomas one
and 2 months after the first operation, respectively. Akimo-
to et al. (2) also reported the malignant recurrence of the
intracranial trigeminal nerve schwannoma 4 months later
initial resection. In rare cases (8, 9, 11), VS displayed rapid
growth, but its malignant transformation following micro-
surgery is very unusual and thus hardly expected. In McLean’ s
report (1) of the first case of malignant transformed VS after
removal, the patient developed a recurrence 11 months post-
surgery and the histology revealed malignant features. But
the histopathologic findings of the original tumor was not
enough to definitely convince the benign nature because of
its increased cellularity and mitoses, albeit in a small focus.
In present case, one might suggest that the original tumor
did harbor a malignant component which was not removed
at the first surgery, although the clinicopathological find-
ings are certainly consistent with rapid malignant progres-
sion of a schwannoma. But we fulfill grossly complete resec-
tion of the tumor at the first surgery and confirmed total
excision on the postoperative imagings. Although an alter-
native explanation that the initial tumor had both benign
and malignant components, and that due to with incom-
plete resection, the malignant component rapidly recurred
was also considered, retrospective careful examinations of
the slides of the original tumor showed no presence of any
foci of malignant schwanoma. Therefore the possibilities of
intratumoral heterogeneity and insufficient tissue due to
sampling errors of the first surgical specimen could be in
the discard. Han et al. (6) reported a case of VS transformed
into a malignant schwannoma with rhabdomyosarcomatous
differentiation 10 months after near-total removal of the
original tumor. Although the histogenesis of such change
remains uncertain, some physicians have suggested the pos-
sibility of a dedifferentiating potential for malignant Schwann
cells in  schwannomas (1, 8-11). Furthermore, the postoper-
ative irradiation or surgical trauma may exacerbate the malig-
nant progression in the partially removed cases, such as malig-
nant progression of cerebral astrocytic tumors (9). Difficulties
in establishing the pathogenesis of malignant nerve-sheath
tumors include the extreme rarity of such tumors arising
from a previously benign schwannoma and the presence
cells other than Schwann cells that give rise to a malignant
tumor (1).
In microscopic examination of benign VS, varying degree
of cellular polymorphism is acceptable, but mitotic figures
are mostly infrequent (4, 9, 10, 12). For the histological diag-
nosis of a malignancy, some insisted on the requirements of
increased cellularity, atypical mitoses, poor cellular differen-
tiation, high mitotic rate, and/or extensive invasion in a pre-
viously unoperated field. Alternatively, the use of cell prolif-Malignant Vestibular Schwannoma 821
eration markers might be useful. Yokoyama et al. (11), and
Tanabe et al. (8), mentioned that VS with high MIB-1 stain-
ing index greater than 2% showed rapid growth, had a high-
er tendency to recur, and suggested the usefulness of this
index for the management planning of VS. In our case, MIB-
1 index was 3% and 2% in the specimens at first and sec-
ond recurrence, respectively. Intranuclear deposits of the
p53 protein is demonstrated in the majority of malignant
schwannomas and this expression indicates mutation in the
TP53 tumor suppressor gene (9). Analysis of the reported
cases of malignant schwannoma or benign schwannoma
with malignant transformation of the cranial nerves did not
demonstrated the molecular evidence of biological malig-
nancy or genetic mutation of the recurrent tumor. In our
case, neither electron microscopy nor immunohistochemical
stainings for desmin, myosin, vimentin, or myoglobin was
carried out because the surgical specimens showed uniform
histologic features and did not contain any heterogeneous
cellular components such as rhabdomyoblasts on the microscop-
ic findings. Immunohistochemically, the schwannian origin of
nerve sheath tumors can be confirmed by their positive stain-
ing for S-100 protein, but the immunostaining results for the
malignant Schwann cells are variable and often negative (7, 9).
Thus, it is possible to consider that the S-100 protein expres-
sion could reflect the degree of Schwann cells. Malignant
schwannomas, at times, reveal a progressive anaplasia, al-
though the tumors remained encapsulated (9), but in our
case, there was no significant pathological differences between
the tumors at first and second recurrence. The cellular schwan-
noma which makes up about 10% of schwannomas has a
higher than usual recurrence rate, especially if they occur in
the cerebellopontine angle. But It is composed entirely of
well differentiated Schwann cell and is well stained by S-100
protein. The cellular variant is not malignant (9, 10, 12). To
differentiate low and high-grade malignant schwannomas
from a cellular schwannoma, the required mitotic count varies
from a rare or isolated mitosis to mitoses numbering more
than 5 per 10 high-power fields. In present case, the micro-
scopic findings of the initial tumor specimen are certainly
that of a typical schwannoma, with hyalinized vessels and S-
100 immunoreactive schwannoma cells. The histologic fea-
tures of the recurrent tumor are that of a hypercellular, pro-
liferative spindle cell tumor, best termed malignant periph-
eral nerve sheath tumor.
In conclusion, our case might serve a rare example of malig-
nant transformation of a typical VS following microsurgery.
VS, essentially a benign tumor, appears to have a rare capac-
ity to develop into malignant schwannoma. In this regard,
we should take into account a potential risk of tumor pro-
gression, and malignant change in VS especially in a patient
with a very short-term and repeated recurrence.
REFERENCES
1. McLean CA, Laidlaw JD, Brownbill DS, Gonzales MF. Recurrence
of acoustic neurilemoma as a malignant spindle-cell neoplasm. J
Neurosurg 1990; 73: 946-50.
2. Akimoto J, Ito H, Kudo M. Primary intracranial malignant schwan-
noma of trigeminal nerve. A case report with review of the literature.
Acta Neurochir (Wien) 2000; 142: 591-5.
3. Levy WJ, Ansbacher L, Byer J. Primary malignant nerve sheath
tumor of the gasserian ganglion. A report of two cases. Neurosurgery
1983; 13: 572-6.
4. Best PV. Malignant triton tumor in the cerebellopontine angle: report
of a case. Acta Neuropathol (Berl) 1987; 74: 92-6.
5. Comey CH, McLaughlin MR, Jho HD, Martinez AJ, Lunsford LD.
Death from a malignant cerebellopontine angle triton tumor despite
stereotactic radiosurgery: case report. J Neurosurg 1998; 89: 653-8.
6. Han DH, Kim DG, Chi JG, Park SH, Jung HW, Kim YG. Malig-
nant triton tumor of the acoustic nerve: case report. J Neurosurg
1992; 76: 874-7.
7. Kudo M, Matsumoto M, Terao H. Malignant nerve sheath tumor of
acoustic nerve. Arch Pathol Lab Med 1983; 107: 293-7.
8. Tanabe M, Watanabe T. MIB-1 and schwannoma. J Neurosurg 1999;
90: 809-10.
9. Urich H, Tien RD. Tumors of the cranial, spinal, and peripheral
nerve sheaths. In: Bigner DD, McLendon RE, Bruner JM, editors,
Russel and Rubinstein’ s pathology of tumors of the nervous system,
6th ed, Vol 2. London: Arnold, 1998; 167-70.
10. Woodruff JM, Selig AM, Crowley K, Allen PW. Schwannoma
(Neurilemoma) with malignant transformation: a rare, distinctive
peripheral nerve tumor. Am J Surg Pathol 1994; 18: 882-95.
11. Yokoyama M, Matsuda M, Nakasu S, Nakajima M, Handa J. Clini-
cal significance of Ki-67 staining index in acoustic neurinoma. Neu-
rol Med Chir 1996; 36: 698-702.
12. Hajdu SI: Schwannomas. Mod Pathol 1995; 8: 109-15.